Biotechnology

After a 20-year drought, positive Phase 3 data for oral olorofim signals a safer, potent new option against a deadly fungus, promising a major market shake-up.

An AMWC 2026 award for RRS® HA Long Lasting signals a market shift. How Skin Tech Pharma Group is creating a new category beyond fillers and boosters.

An Arkansas lab's $30 million settlement with the DOJ offers a rare look into 'lean lab' models and the fine line between business and patient care.

GSK and Spero Therapeutics have won FDA approval for Utebzi, the first oral carbapenem for complex UTIs, a move that could slash healthcare costs.

Kilroy Realty’s major debt restructuring isn't just a financial footnote; it's a strategic masterclass in navigating market turmoil and unlocking future growth.

A partnership between Chef Carla Hall and The Fresh Market shows how retail fundraising directly enables cutting-edge diagnostics and treatments in the fight against Alzheimer's.

Healthcare firm Cosmos Health is diversifying into the crowded skincare market with a DTC brand. Can its science-first approach disrupt the beauty industry?

A Florida hospital just rebuilt a baby's heart in stages. It's not just a medical first; it's a new blueprint for innovation where execution trumps hype.

AB Science has secured a US patent until 2042 for masitinib, a targeted therapy for advanced prostate cancer, offering new hope where few options exist.

As RESTEM presents at BIO 2026, the company showcases its novel cell therapies aiming to reprogram the immune system, not just manage symptoms.

Model N's acquisition of Kalderos targets the chaotic 340B drug discount program, a system where 99% of pharma leaders lack real-time data visibility.

With $4.3M in seed funding and a roster of industry titans, Acurion is poised to commercialize its OncoGaze™ AI, aiming to make precision oncology faster.

A new network aims to speed up clinical trials by recruiting patients from med spas and longevity clinics. Is this the future of medicine or a risky new frontier?

With an oversubscribed $7.2M Series A, Icarus Medical is leveraging 3D printing and novel biomechanics to redefine treatment for millions with knee pain.

With a novel FDA clearance for its at-home UVB device, Solius Labs isn't just launching a product; it's creating a new market for personalized medicine.

A landmark victory at the 2026 Autoflower World Cup validates 42 Fast Buds' strategic pivot to in-house cultivation, setting a new benchmark for the industry.

A groundbreaking partnership turns millions of registered organ donors into potential living kidney donors, tackling a waitlist of 90,000 with one simple step.

Chronic fatigue, anxiety, and burnout are surging. A new wave of data-driven, integrative medicine claims to have the answer, moving beyond symptoms to the root cause.

A key regulatory win in Abu Dhabi opens a new international front for NeOnc's war on brain tumors, backed by novel science and significant insider buying.

A new partnership between Medventions and Mitacs aims to fix Canada's innovation gap by embedding engineers directly into clinics. Here's how it works.